TMSH (TransGlobal Assets) ROCE %: 0.00% (As of Dec. 2011)


What is TransGlobal Assets ROCE %?

TransGlobal Assets TMSH ROCE % is 0.00% as of Dec. 2011.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TransGlobal Assets's annualized ROCE % for the quarter that ended in Dec. 2011 was 0.00%.

TransGlobal Assets  (OTCPK:TMSH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

TransGlobal Assets ROCE % Related Terms

TransGlobal Assets ROCE % Historical Data

* Premium members only.

The historical data trend for TransGlobal Assets's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TransGlobal Assets ROCE % Chart

TransGlobal Assets Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
ROCE %
0.00 0.00 0.00 0.00 0.00

TransGlobal Assets Semi-Annual Data
Dec07 Dec08 Dec09 Dec10 Dec11
ROCE % 0.00 0.00 0.00 0.00 0.00

TransGlobal Assets ROCE % Calculation

TransGlobal Assets's annualized ROCE % for the fiscal year that ended in Dec. 2011 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2011 )  (A: Dec. 2010 )(A: Dec. 2011 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2011 )  (A: Dec. 2010 )(A: Dec. 2011 )
=-0.54/( ( (0.014 - 1.253) + (0.015 - 1.896) )/ 2 )
=-0.54/( (-1.239+-1.881)/ 2 )
=-0.54/-1.56
=34.62 %

TransGlobal Assets's ROCE % of for the quarter that ended in Dec. 2011 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2011 )  (Q: Dec. 2010 )(Q: Dec. 2011 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2011 )  (Q: Dec. 2010 )(Q: Dec. 2011 )
=-0.54/( ( (0.014 - 1.253) + (0.015 - 1.896) )/ 2 )
=-0.54/( ( -1.239 + -1.881 )/ 2 )
=-0.54/-1.56
=0 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2011) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
TransGlobal Assets (TMSH) has a ROCE % of 0.00% as of Dec. 2011.
Is TransGlobal Assets' ROCE % too high?
TransGlobal Assets' current ROCE % is 0.00%.
How does TransGlobal Assets' ROCE % compare to CLDOF?
TransGlobal Assets' ROCE % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TransGlobal Assets's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransGlobal Assets stock overvalued right now?
TransGlobal Assets (TMSH) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For TransGlobal Assets (TMSH), the current ROCE % is 0.00% as of Dec. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TransGlobal Assets Business Description

Address No. 14, 5555 Sagamore Avenue, Portsmouth, NH, USA, 03801
TransGlobal Assets Inc through its subsidiary Mindwell Solutions Group LLC (MWSG), the company develops proprietary solutions that harness AI, biometric analysis, and behavioral data to address high-growth markets, including mental health, relationship wellness, performance analytics, and sports/entertainment. and also offers a pioneer in transforming the health and wellness industries through cutting-edge products and services. The products and services are focused on being at the forefront of the health and wellness sectors, developing technologies and solutions that are driving industry growth and transforming lives. The portfolio includes a range- of-products and services, from telemedicine platforms to wellness retreats and natural health remedies.